inflammatory microenvironment cr complex heterogeneous5,6,10,11 perform singlecell level analysis immune nonimmune cell healthy individual patient heterogeneous cr include cr nasal polyp crswnp cr without nasal polyp crssnp former divide eosinophilic crswnp ecrswnp noneosinophilic crswnp necrswnp scrnaseq identify multiple diseasespecific cell subset molecule contribute heterogeneity cr subtypes notably alox15 macrophage contribute pathogenesis type 2 immunity ecrswnp secrete chemokines recruit eosinophil monocyte th2 cell blockade alox15 result reduction expression type 2 immune chemokines human macrophage inhibit type 2 inflammation mouse model eosinophilic rhinosinusitis investigate airway cellular microenvironment vary different subtypes cr use 10x genomics chromium droplet scrnaseq profile cellular landscape nasal mucosa healthy control hcs n 5 patient crssnp n 5 necrswnp n 5 ecrswnp n 6 supplementary table 1. transcriptomic data obtain 122,664 cell include 74,211 immune cell 46,692 nonimmune cell 1,761 cycle cell supplementary table 2. define cell population structure microenvironment perform unsupervised graph cluster datasets divide total 73 cell cluster 8 major group good reproducibility fig 1a b extend data fig 1a epithelial cell predominantly find hcs whereas immune cell include myeloid cell cell b cell significantly enrich patient cr fig 1c together observation reflect shift cellular microenvironment chronic inflammation unsupervised subclustering major cell type identify 28,466 epithelial cell subclustered 16 subset could classify accord previously define marker five common cell type basal cell krt5 tp63 goblet cell muc5ac itln1 submucosal glandular cell lyz ltf ciliated columnar cell ciliated cell foxj1 pifo nonciliated secretory columnar cell secretory cell scgb1a1 two rare cell type ionocytes cftr foxi myoepithelial cell krt14 acta2 fig 2ac extend data fig 1b consistent traditionally recognize evolution airway barrier epithelial cell pseudotime analysis data identify four classic differentiation trajectory lead basal cell secretory cell goblet cell glandular cell ciliated cell hc fig 2d e extend data fig 1c cr epithelial cell remain undifferentiated basal cell especially ecrswnp fig 2b f lead loss secretory ciliated cell contrast hcs patient necrswnp show significant loss secretory cell patient ecrswnp show significantly reduce ciliated secretory cell fig 2b f indicate impair barrier function developmental proliferative activity basal cell different cr subtypes extend data fig 1d supplementary text 1. basal cell hyperplasia couple loss barrier function correlate disease severity especially ecrswnp line poor prognosis analysis differentially express gene degs indicate basal cell hcs highest expression gene associate antimicrobial host defense bpifa1 antiinflammatory response scgb1a1 necrswnp basal cell higher expression gene associate host defense response include complement component c3 c1r antibacterial protein lcn2 major histocompatibility complex mhc class ii molecule relate chaperone cd74 s100a9 inducer neutrophil chemotaxis adhesion response proinflammatory cytokine interleukin1¦Â il1¦Â whereas basal cell ecrswnp lack expression protective gene fig 2g contrast basal cell ecrswnp show highest expression proinflammatory gene especially link type 2 inflammation include nos2 notably exhale nitric oxide level important clinical biomarker eosinophilic airway inflammation il4 il13induced gene alox15 postn eosinophilderived chemokines ccl26 adhesion molecule cd44 solute carrier family protein slc protease inhibitor cystatins serpins fig 2g goblet cell ciliated cell glandular cell also distinctive gene expression profile associate type 2 inflammation ecrswnp extend data fig 1fh supplementary text 2. stromal cell include fibroblast smooth muscle cell endothelial cell find play important role tissue remodel maintain homeostasis cellular microenvironment extend data fig 2 3 supplementary text 3 4. together observation indicate impair epithelial barrier associate cr pathogenesis next divide total lymphocyte 16 subset base previously define marker fig 3a extend data fig 4a cd8 cell especially tissueresident memory cd8 cell cell abundant healthy nasal mucosa cd4 cell ecrswnp significantly fewer cd8 cell odds ratio 0.29 lower expression scgb1a1 bpifa1 cd4 cell naive cd4 cell regulatory cell cell t2 cell compare hcs fig 3b extend data fig 4b ecrswnp specific enrichment t2 cell 95.49 hcs 56.60 crssnp 62.49 necrswnp type 2 innate lymphoid cell ilc2s 9.33 hcs 11.96 crssnp 10.30 necrswnp cell type drive type 2 immunity express transcription factor gata3 fig 3b c ilc2s t2 cell express type 2 cytokine il4 il5 il13 macrophagestimulating factor csf1 prostaglandin d2 pgd encode hpgds tespa1 fig 3c ilc2s t2 cell express substantial amount il1rl1 receptor basal cellderived il33 fig 3c important initiate factor type 2 response ecrswnp addition also express receptor downstream type 2 effector molecule include il2ra cysltr1 ptgdr2 pparg fig 3c therefore patient ecrswnp present sign ilc2s t2 cellsdriven type 2 immunity addition ecrswnp sample elevate amount cytotoxic cd8 effector cell cell 2.97 crssnp natural killer nk cell express cx3cr1 fcgr3a granzymes prf1 gnly define cx3cr1 nk cell 5.84 crssnp decrease sell nk cell 0.20 necrswnp cxcr6 nk cell 0.36 necrswnp fig 3b supplementary text 5. sell nk cell cxcr6 nk cell express xcl1 xcl2 encode xcl1 xcl2 perform immunologic surveillance homeostasis maintenance function fig 3bd together observation indicate enrich t2 cell ilc2s well cytotoxic cx3cr1 nk cell could contribute pathogenesis type 2 inflammation ecrswnp classify b cell naive b cell memory b cell plasma cell base previously define marker fig 3e extend data fig 4c plasma cell home airway epithelial mucosa ccr10 bind ccl28expressing epithelial cell extend data fig 5. compare plasma cell ecrswnp necrswnp il5ra plasma cell express ighe ighg4 enrich ecrswnp whereas il5ra plasma cell express ighm enrich necrswnp fig 3eg production immunoglobulin e ige indicate important role allergic reaction pathogenesis type 2 immunity ecrswnp high local ige level nasal polyp associate faster nasal polyp growth recurrence surgery whereas igm production patient necrswnp imply close relationship sinonasal infection consistent notable association type 3 immunity presence pu noneosinophilic cr define crssnp necrswnp hereafter together observation indicate important role il5ra plasma cell ige pathogenesis type 2 immunity ecrswnp validate scrnaseq data perform mass cytometry independent cohort patient three hcs three patient crssnp three patient necrswnp five patient ecrswnp scrnaseq mass cytometry show consistent cell cluster extend data fig 7ag enrichment cx3cr1 trm hcs compare cr enrichment cd209 trm cr higher ecrswnp compare hcs significant decrease cd8 cell frequency ecrswnp compare hcs well consistent expression marker gene highest expression cd1b ecrswnp cdc2s compare hcs extend data fig 7h immunofluorescence stain indicate highest expression alox15 ecrswnp significant colocalization alox15 cd68 macrophage eosinophil major basic protein embp prg2 eosinophil nasal tissue fig 6a extend data fig 8a next enzymelinked immunosorbent assay elisa analysis indicate strong correlation expression alox15 nasal tissue tissue eosinophil count serum total ige weak correlation sinonasal outcome test snot22 score compute tomography lundmackay score extend data fig 8b indicate association alox15 pathogenesis type 2 immunity macrophage differentiate cd14 monocyte isolate peripheral blood hcs stimulate il4 il13 vitro increase alox15 protein expression compare unstimulated control fig 6b among 18 cytokine chemokines detect scrnaseq macrophage supplementary table 3 expression ccl13 ccl17 ccl18 ccl24 higher macrophage stimulate il4 il13 compare unstimulated control fig 6c extend data fig 9a addition pd146176 inhibitor 15lo significantly inhibit il4 il13induced expression ccl13 ccl17 ccl18 ccl24 macrophage fig 6c extend data fig 9a short interfere rna sirna silence expression alox15 macrophage extend data fig 9b significantly inhibit il4 il13induced expression ccl13 ccl17 ccl18 ccl24 fig 6d extend data fig 9c chemokines recruit cd4 cell perform chemotactic migration assay cd4 cell migration enhance incubation condition medium cm unstimulated macrophage compare serumfree control medium equally enhance cm macrophage stimulate il4 il13 fig 6e effect il4 andor il13 cd4 cell migration completely abate 15lo inhibitor pd146176 fig 6e indicate high expression alox15 macrophage may contribute recruitment proinflammatory immune cell regulate chemokine expression investigate whether alox15 blockade could improve eosinophilic rhinosinusitis vivo use mouse model papaininduced eosinophilic rhinosinusitis fig 6f extend data fig 9d intragastric administration pd146176 papaintreated mouse significantly decrease infiltration cd4 cell b220 b cell f480 macrophage siglecf eosinophil nasal mucosa day 14 16 18 compare papainonly mouse fig 6f g. total ige serum fig 6h amount il4 il5 il13 nasal mucosa fig 6i reduce pd146176treated mouse compare papainonly mouse day 14 16 18. treatment pd146176 inhibit alox15 activity reduce expression 15lo murine nasal mucosa compare papainonly mouse fig 6j possibly indirectly inhibitory effect il4 il13 production necessary expression alox15 result suggest inhibition alox15 could alleviate type 2 inflammation reduce infiltration type 2 inflammatory immune cell downstream